Tectonic Therapeutic (TECX) has had the best year this year by a US stock this year, returning 6,012,400%.

ASSET	YEAR	% RETURN
Tectonic Therapeutic (TECX)	2024	6,012,400%
Nexalin Technology (NXLIW)	2024	7,787.32%
Iteris (ITI)	2024	5,230.81%
Wearable Devices (WLDSW)	2024	3,117.14%
GeneDx (WGS)	2024	2,815.19%
Triller (ILLRW)	2024	2,804.92%
TSS, Inc Common Stock (TSSI)	2024	2,637.04%
Bright Minds Biosciences (DRUG)	2024	2,271.14%
Sezzle Inc Common Stock (SEZL)	2024	2,109.43%
LENZ Therapeutics (LENZ)	2024	1,927.07%
GeneDx (WGSWW)	2024	1,611%
BM Technologies Inc WT (BMTX.WT)	2024	1,560.65%
Fitell Corporation Ordinary Shares (FTEL)	2024	1,559.87%
Zivo Bioscience (ZIVO)	2024	1,447.41%
NeoVolta Inc Warrant (NEOVW)	2024	1,341.44%
FTAC Emerald Acquisition (FLDDW)	2024	1,333.96%
CompoSecure (CMPOW)	2024	1,260.53%
Codere Online Luxembourg SA Warrants (CDROW)	2024	1,144.7%
Mobiquity Technologies (MOBQ)	2024	1,144.19%
Monopar Therapeutics (MNPR)	2024	1,114.5%
CleanSpark, Inc Warrant (CLSKW)	2024	1,012.35%
Palladyne AI (PDYNW)	2024	999%
Dave (DAVE)	2024	958.4%
Root (ROOT)	2024	948.27%
Red Cat (RCAT)	2024	907.87%